Economic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base
暂无分享,去创建一个
[1] J. Frenk. Disease control priorities in developing countries , 2006 .
[2] T. Edejer,et al. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector , 2003, Cost effectiveness and resource allocation : C/E.
[3] D. Yach,et al. Research gap in cardiovascular disease in developing countries , 2003, The Lancet.
[4] D. Walker. Cost and cost-effectiveness guidelines: which ones to use? , 2001, Health policy and planning.
[5] J. Fox-Rushby,et al. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. , 2000, Health economics.
[6] J. Fiedler,et al. Cost analysis as a vitamin A program design and evaluation tool: a case study of the Philippines. , 2000, Social science & medicine.
[7] V. Wiseman,et al. Burden of disease and priority setting. , 2000, Health economics.
[8] J. Fox-Rushby,et al. Economic evaluation of parasitic diseases: A critique of the internal and external validity of published studies , 2000, Tropical medicine & international health : TM & IH.
[9] Boheng Zhang,et al. Combined α fetoprotein testing and ultrasonography as a screening test for primary liver cancer , 1999 .
[10] A. Williams,et al. Calculating the global burden of disease: time for a strategic reappraisal? , 1999, Health economics.
[11] K. Steyn,et al. Improving cost-effectiveness of hypertension management at a community health centre. , 1998, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[12] M Hauswald,et al. Designing a prehospital system for a developing country: estimated cost and benefits. , 1997, The American journal of emergency medicine.
[13] B. O'brien,et al. Cost-benefit analyses in the health-care literature: don't judge a study by its label. , 1997, Journal of clinical epidemiology.
[14] B. Bloch. An economic appraisal of a mobile cervical cytology screening service. , 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[15] G. Guyatt,et al. Cost-effectiveness of inhaled beta-agonists v. oral salbutamol in asthma: a randomized double-blind cross-over study. , 1996, The National medical journal of India.
[16] M. Phillips,et al. The costs and effectiveness of three vitamin A interventions in Guatemala. , 1996, Social science & medicine.
[17] M. Meyer,et al. Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective? , 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[18] P. K. Mohan,et al. Postal follow up of patients with epilepsy. , 1995, The National medical journal of India.
[19] B. Perera. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country. , 1995, Archives of disease in childhood.
[20] R. Blignaut,et al. Effectiveness of two school-based caries preventive programmes. , 1995, The Journal of the Dental Association of South Africa = Die Tydskrif van die Tandheelkundige Vereniging van Suid-Afrika.
[21] L. Walters,et al. Pharmaco-economic assessment of the HMG-CoA reductase inhibitors. , 1994, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[22] M. Phillips,et al. Family-Based Intervention for Schizophrenic Patients in China , 1994, British Journal of Psychiatry.
[23] A Briggs,et al. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. , 1994, Health economics.
[24] D. Jamison,et al. Disease Control Priorities in Developing Countries , 1993 .
[25] D. Woodward,et al. World Bank's world development report , 1993, The Lancet.
[26] K. Gerard. Cost-utility in practice: a policy maker's guide to the state of the art. , 1992, Health policy.
[27] S. Wangsuphachart. Low osmolar (non-ionic) contrast media versus high osmolar (ionic) contrast media in intravenous urography and enhanced computerized tomography: a cost-effectiveness analysis. , 1991, The Southeast Asian journal of tropical medicine and public health.
[28] R. Parris,et al. Clinical and cost effectiveness of prophylactic parenteral penicillin in the care of simple wounds undergoing suture repair. , 1991, The West Indian medical journal.
[29] A. Koch,et al. The value and cost-effectiveness of a home-visiting programme for psychiatric patients. , 1990, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[30] D. Eddy. Setting priorities for cancer control programs. , 1986, Journal of the National Cancer Institute.
[31] P. Disler,et al. The cost effectiveness of the Philani Nutrition Day Centre in Crossroads squatter camp, Cape Town. , 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[32] Health systems: improving performance , 2000 .
[33] C. Murray,et al. Development of WHO Guidelines on Generalised Cost-Effectiveness Analysis , 1999 .
[34] R. Sutter,et al. Using cost-effectiveness analysis to evaluate targeting strategies: the case of vitamin A supplementation. , 1997, Health policy and planning.
[35] A. Ashworth,et al. Cost-effective treatment for severely malnourished children: what is the best approach? , 1997, Health policy and planning.
[36] M. Veller,et al. The cost and benefit of prophylaxis against deep-vein thrombosis in elective hip replacement , 1997 .
[37] J. Wambani. Halothane consumption under varying breathing circuit designs. , 1996, East African medical journal.
[38] E. Marseille. Cost-effectiveness of cataract surgery in a public health eye care programme in Nepal. , 1996, Bulletin of the World Health Organization.
[39] R. N. Grosse,et al. Impact of nutrition education and mega-dose vitamin A supplementation on the health of children in Nepal. , 1996, Bulletin of the World Health Organization.
[40] J. Aluoch. The presence of sickle cells in the peripheral blood film. Specificity and sensitivity of diagnosis of homozygous sickle cell disease in Kenya. , 1995, Tropical and geographical medicine.
[41] H Saxenian,et al. Design, content and financing of an essential national package of health services. , 1994, Bulletin of the World Health Organization.
[42] R. Lozano,et al. The epidemiologic transition and health priorities. , 1993 .
[43] M. Mengistu,et al. Inpatient or outpatient initiation of insulin therapy. Experience and cost effective analysis in a suboptimal clinical setting. , 1991, Tropical and geographical medicine.
[44] K. Thimasarn,et al. Economic analysis of several types of malaria clinics in Thailand. , 1991, Bulletin of the World Health Organization.
[45] A. Feksi,et al. Determining the prevalence of epilepsy in the semi-urban population of Nakuru, Kenya, comparing two independent methods not apparently used before in epilepsy studies. , 1988, Neuroepidemiology.